6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Low Bone Density in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adami, S; Fracassi, E; Gatti, D; Idolazzi, L; Viapiana, O | 1 |
Chambers, TJ; Gallagher, AC; Laversuch, CJ; Tobias, JH | 1 |
1 review(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Low Bone Density
Article | Year |
---|---|
Neridronic acid for the treatment of bone metabolic diseases.
Topics: Adult; Bone Diseases, Metabolic; Child; Child, Preschool; Clinical Trials as Topic; Diphosphonates; Drug Evaluation, Preclinical; Humans; Infant; Infant, Newborn; Italy; Osteitis Deformans; Osteogenesis Imperfecta | 2009 |
1 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Low Bone Density
Article | Year |
---|---|
Aminohexane bisphosphonate suppresses bone turnover in postmenopausal women more rapidly than oestrogen-gestagen therapy.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Creatinine; Diphosphonates; Estrogens; Female; Humans; Middle Aged; Osteocalcin; Postmenopause; Progestins; Time Factors | 1996 |